LABCORP HOLDINGS INC. — Director's Dealing 2016

Jun 15, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LABORATORY CORP OF AMERICA HOLDINGS (LH)
CIK: 0000920148
Period of Report: 2016-06-13

Reporting Person: KING DAVID P (Director, President & CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-06-13	Common Stock	M	123839	$70.15	Acquired	271210.2512	Direct
2016-06-13	Common Stock	S	73455	$127.7622	Disposed	197755.2512	Direct
2016-06-13	Common Stock	S	45884	$128.7945	Disposed	151871.2512	Direct
2016-06-13	Common Stock	S	4500	$129.4724	Disposed	147371.2512	Direct
2016-06-13	Common Stock	M	72561	$70.15	Acquired	219932.2512	Direct
2016-06-13	Common Stock	S	72561	$127.6463	Disposed	147371.2512	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-06-13	Non-qualified Stock Options	$70.15	M	123839	Disposed	2020-02-09	Common Stock (123839)	Direct
2016-06-13	Non-qualified Stock Options	$70.15	M	72561	Disposed	2020-02-09	Common Stock (72561)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	24383	Indirect
Common Stock	19046	Indirect

Footnotes

F1: Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934.

F2: The price of $127.7622 per share represents a weighted average of sales prices ranging from $127.36 to $128.35 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.

F3: The price of $128.7945 per share represents a weighted average of sales prices ranging from $128.36 to $129.35 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.

F4: The price of $129.4724 per share represents a weighted average of sales prices ranging from $129.36 to $129.72 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.

F5: The price of $127.6463 per share represents a weighted average of sales prices ranging from $127.43 to $128.14 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.

F6: Employee stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2008 Stock Incentive Plan.

F7: The option vested in three equal annual installments beginning on 02/09/2010 and is now fully exercisable.